NOI for DLS PLATE READER

The National Institutes of Health, through its Office of Logistics and Acquisition Operations in Bethesda, Maryland, is soliciting quotations for a Dynamic Light Scattering (DLS) Plate Reader under solicitation number 75N98026Q00845, issued on July 21, 2026, with responses due by August 5, 2026, at 9:00 a.m. Eastern Daylight Time. This acquisition is conducted as a non-competitive commercial item procurement under FAR Subpart 12.6, following streamlined procedures and applying standard commercial terms through FAR clauses 52.204-7, 52.212-1, 52.212-2, and 52.212-4. The contract will be awarded on a firm fixed-price basis to the offeror whose proposal represents the best value, considering factors including past performance, technical capability, special features, trade-in considerations, expected lifecycle, warranty, maintenance availability, and environmental or energy efficiency, though no weights or adjectival ratings are assigned. The item must be a Wyatt series DLS instrument compatible with existing NIH laboratory systems to ensure data comparability and minimize training needs, and delivery is to occur at the National Institute on Aging’s Laboratory of Genetics and Genomics in Baltimore, Maryland, under FOB DESTINATION terms. All offerors must be actively registered in SAM.gov, provide a Unique Entity Identifier and Taxpayer Identification Number, and certify their business size status under NAICS code 334516, with no set-aside provisions in effect. Proposals must be submitted electronically to Calvin Robinson, the Procuring Contracting Officer, using the Standard Form 18 template and must include product specifications, catalog numbers, warranty details, and delivery timelines. No packaging, marking, inspection criteria, or invoicing procedures beyond standard commercial practices are specified, and no Contracting Officer’s Representative or technical representative has been designated. There is no estimated contract value provided, as pricing will be determined through offeror responses, and the acquisition is not expected to exceed the simplified acquisition threshold.